Organ-on-a-Chip systems for new drugs development

Area of Science:

• Biotechnology
• Microfluidics
• Physiology

Background:

• Organ-on-a-chip (OoC) technology emerges as a novel alternative to traditional animal models and cell cultures.
• OoC systems simulate organ physiology and responses to external stimuli within microfluidic devices.
• These systems hold significant potential for drug development and personalized medicine.

Purpose of the Study:

• To review the key considerations for designing and utilizing OoC systems.
• To highlight the materials, methods, and cell lines employed in OoC development.
• To discuss the conditions necessary for optimal OoC system function and application.

Main Methods:

• Integration of materials engineering, cell culture, microfluidics, and physiology.
• Simulation of organ, tissue, barrier, or physiological phenomena in a controlled environment.
• Three-dimensional arrangement of diverse cell lines within polymer-based microdevices.

Main Results:

• OoC technology demonstrates superior potential for predicting drug efficacy, toxicity, and pharmacokinetic profiles compared to cell cultures.
• These systems enable the study of physiological and pathophysiological processes and inter-system interactions.
• The review presents examples of OoC applications and identifies challenges for future development.

Conclusions:

• OoC systems offer a powerful alternative for pharmacological, pharmacokinetic, and toxicological studies.
• Further development of robust OoC systems is crucial for advancing drug discovery and personalized therapies.
• This review serves as a reference for researchers developing and applying OoC technology.